Sonomax Hearing Healthcare Inc.

Sonomax Hearing Healthcare Inc.

November 30, 2007 17:01 ET

Correction From Source/Sonomax: Third Quarter Conference Call Will Be December 12th

MONTREAL, QUEBEC--(Marketwire - Nov. 30, 2007) - The date and time of the third quarter conference call of Sonomax Hearing Healthcare Inc. (TSX VENTURE:SHH) will be Wednesday, December 12th, 2007 from 10:00a.m. to 11:00 a.m., and not as stated in yesterday's press release.

Sonomax invites all interested parties to participate by dialing 1-416-644-3415, or toll free 1-800-732-0232 (North America only). International callers please dial +1 416-644-3415. You will be put on hold until the conference call begins.

The first portion of the call will be dedicated to presenters. A question and answer session will follow, at which time the operator will direct participants as to the correct procedure for submitting questions.

During the conference call, Sonomax's management will update participants on the company's partnerships with Aearo, HearAtLast in Wal-Mart, its international licensee network, and its latest announcement which references Sonomax's retail collaboration in the United States with Virgin Entertainment Group. Management will also discuss the company's plans to penetrate the North American and worldwide consumer and military markets - music and entertainment, Bluetooth™ cellular, gaming, consumer hearing protection, instant-fit digital hearing aids, and military hearing protection and communications devices.

A live Web cast will be available at:

A replay of the conference will be available on our website at:

This news release contains certain forward-looking statements that reflect the current views and/or expectations of Sonomax Hearing Healthcare Inc. with respect to its performance, business and future events. Such statements are subject to a number of risks, uncertainties and assumptions. Actual results and events may vary significantly.

The TSX Venture Exchange has not reviewed and does not accept responsibility for the adequacy or accuracy of this release.

Contact Information